Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Bleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others), Drug Class [Plasma-derived Coagulation Factor Concentrates (Factor VIII, Factor IX, Factor for Von Willebrand Disease, and Activated Prothrombin Complex Concentrates), Recombinant Coagulation Factor Concentrates (Factor VIII, Factor for Von Willebrand Disease, and Factor IX), Desmopressin, Antifibrinolytics, Fibrin Sealants, and Others)] - Global Opportunity Analysis and Industry Forecast, 2021-2028
| A03237 | Pages: NA | Feb 2021 | 3341 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bleeding Disorders Treatment Market
Request Now !Bleeding disorder refers to a condition that disrupts the process of coagulation of blood by preventing the formation of blood clots in hemophilic patients or patients with other bleeding disorders. Most of these bleeding disorders are inherited but some are acquired due to liver diseases, side effects of certain medications, low red blood cell count, vitamin K deficiency and others. The global bleeding disorders treatment market is expected to witness rapid growth during the forecast period due to increase in the number of people suffering from liver diseases, anemia, and other blood coagulation disorders.
The global bleeding disorders treatment market is driven by increase in the number of diagnosed patients with bleeding disorders, growth in awareness about bleeding disorders especially hemophilia, and proactive government initiatives in the developed countries towards establishing a wide network of diagnosis and treatment centers supplementing the market growth. However, lack of access to proper treatment due to high cost of medication and dearth of skilled health professionals restrain the market growth. Conversely, Asia-Pacific is expected to provide opportunities for the market growth due to increase in the awareness related to the treatment of bleeding disorders.
The global bleeding disorder market is segmented based on type, drug class, and region. On the basis of type, it is classified into hemophilia A, hemophilia B, Von Willebrand disease, and others. Based on drug, it is categorized into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others.
The coagulation factor concentrates segment is further divided into factor VIII, factor IX, factor for Von Willebrand disease, and activated prothrombin complex concentrate. On the basis of recombinant coagulation factor concentrates, the market is classified into factor VIII, factor for Von Willebrand disease, and factor IX. The market is analyzed based on region across North America, Europe, Asia-Pacific, and LAMEA further country level analysis of the region is provided to determine the market size and forecast for each segment and sub-segment of the market in various countries across the globe.
The key players profiled in the report include Novo Nordisk, Bayer AG, Baxter International Inc., Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Xenetic Biosciences, Inc., Bristol-Myers Squibb Company, Sanofi, Amgen, Inc., Janssen Global Services, LLC., and Bioverativ, Inc.
Key Benefits
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis of the industry from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.
- Extensive analysis by product elucidates the use of various medicines for the treatment of hemophilia, clotting factor deficiency, and Von Willebrand disease.
Bleeding Disorders Treatment Market Key Segments:
By Type
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Others
By Drug Class
- Plasma-derived Coagulation Factor Concentrates
- Factor VIII
- Factor IX
- Factor for Von Willebrand Disease
- Activated Prothrombin Complex Concentrate
- Recombinant Coagulation Factor Concentrates
- Factor VIII
- Factor for Von Willebrand Disease
- Factor IX
- Desmopressin
- Antifibrinolytics
- Fibrin Sealants
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Italy
- Spain
- The Netherlands
- Norway
- Russia
- Sweden
- Switzerland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- New Zealand
- Taiwan
- Thailand
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Arabia
- South Africa
- Chile
- Columbia
- Egypt
- Iran
- Israel
- Turkey
- Venezuela
- Rest of LAMEA
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Bleeding Disorders Treatment Market- Global Opportunity Analysis and Industry Forecast, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers